The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma

Natalie K. Heater; Scott Okuno; Steven Robinson; Steven Attia; Mahesh Seetharam; Brittany L. Siontis; Janet Yoon; Sant Chawla; Mohammed M. Milhem; Varun Monga; Keith Skubitz; John Charlson; Angela C. Hirbe; Mia C. Weiss; Brian Van Tine; Mark Agulnik

doi:10.3390/jcm12072561

The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma

Natalie K. Heater, Scott Okuno, Steven Robinson, Steven Attia, Mahesh Seetharam, Brittany L. Siontis, Janet Yoon, Sant Chawla, Mohammed M. Milhem, Varun Monga, Keith Skubitz, John Charlson, Angela C. Hirbe, Mia C. Weiss, Brian Van Tine, Mark Agulnik

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

The treatment of sarcoma necessitates a collaborative approach, given its rarity and complex management. At a single institution, multidisciplinary teams of specialists determine and execute treatment plans involving surgical, radiation, and medical management. Treatment guidelines for systemic therapies in advanced or nonresectable soft tissue sarcoma have advanced in recent years as new immunotherapies and targeted therapies become available. Collaboration between institutions is necessary to facilitate accrual to clinical trials. Here, we describe the success of the Midwest Sarcoma Trials Partnership (MWSTP) in creating a network encompassing large academic centers and local community sites. We propose a new model utilizing online platforms to expand the reach of clinical expertise for the treatment of advanced soft tissue sarcoma.

Original language	English
Article number	2561
Journal	Journal of Clinical Medicine
Volume	12
Issue number	7
DOIs	https://doi.org/10.3390/jcm12072561
State	Published - Apr 2023

Keywords

Midwest Sarcoma Trials Partnership
advanced soft tissue sarcoma
collaboration
multidisciplinary tumor board
sarcoma treatment
targeted therapy

Access to Document

10.3390/jcm12072561

Cite this

Heater, N. K., Okuno, S., Robinson, S., Attia, S., Seetharam, M., Siontis, B. L., Yoon, J., Chawla, S., Milhem, M. M., Monga, V., Skubitz, K., Charlson, J., Hirbe, A. C., Weiss, M. C., Van Tine, B., & Agulnik, M. (2023). The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma. Journal of Clinical Medicine, 12(7), Article 2561. https://doi.org/10.3390/jcm12072561

@article{2977a758c76c43449f7f0b61ea2efe8c,

title = "The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma",

abstract = "The treatment of sarcoma necessitates a collaborative approach, given its rarity and complex management. At a single institution, multidisciplinary teams of specialists determine and execute treatment plans involving surgical, radiation, and medical management. Treatment guidelines for systemic therapies in advanced or nonresectable soft tissue sarcoma have advanced in recent years as new immunotherapies and targeted therapies become available. Collaboration between institutions is necessary to facilitate accrual to clinical trials. Here, we describe the success of the Midwest Sarcoma Trials Partnership (MWSTP) in creating a network encompassing large academic centers and local community sites. We propose a new model utilizing online platforms to expand the reach of clinical expertise for the treatment of advanced soft tissue sarcoma.",

keywords = "Midwest Sarcoma Trials Partnership, advanced soft tissue sarcoma, collaboration, multidisciplinary tumor board, sarcoma treatment, targeted therapy",

author = "Heater, {Natalie K.} and Scott Okuno and Steven Robinson and Steven Attia and Mahesh Seetharam and Siontis, {Brittany L.} and Janet Yoon and Sant Chawla and Milhem, {Mohammed M.} and Varun Monga and Keith Skubitz and John Charlson and Hirbe, {Angela C.} and Weiss, {Mia C.} and {Van Tine}, Brian and Mark Agulnik",

note = "Publisher Copyright: {\textcopyright} 2023 by the authors.",

year = "2023",

month = apr,

doi = "10.3390/jcm12072561",

language = "English",

volume = "12",

journal = "Journal of Clinical Medicine",

issn = "2077-0383",

number = "7",

}

Heater, NK, Okuno, S, Robinson, S, Attia, S, Seetharam, M, Siontis, BL, Yoon, J, Chawla, S, Milhem, MM, Monga, V, Skubitz, K, Charlson, J, Hirbe, AC , Weiss, MC , Van Tine, B & Agulnik, M 2023, 'The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma', Journal of Clinical Medicine, vol. 12, no. 7, 2561. https://doi.org/10.3390/jcm12072561

TY - JOUR

T1 - The Midwest Sarcoma Trials Partnership

T2 - Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma

AU - Heater, Natalie K.

AU - Okuno, Scott

AU - Robinson, Steven

AU - Attia, Steven

AU - Seetharam, Mahesh

AU - Siontis, Brittany L.

AU - Yoon, Janet

AU - Chawla, Sant

AU - Milhem, Mohammed M.

AU - Monga, Varun

AU - Skubitz, Keith

AU - Charlson, John

AU - Hirbe, Angela C.

AU - Weiss, Mia C.

AU - Van Tine, Brian

AU - Agulnik, Mark

PY - 2023/4

Y1 - 2023/4

N2 - The treatment of sarcoma necessitates a collaborative approach, given its rarity and complex management. At a single institution, multidisciplinary teams of specialists determine and execute treatment plans involving surgical, radiation, and medical management. Treatment guidelines for systemic therapies in advanced or nonresectable soft tissue sarcoma have advanced in recent years as new immunotherapies and targeted therapies become available. Collaboration between institutions is necessary to facilitate accrual to clinical trials. Here, we describe the success of the Midwest Sarcoma Trials Partnership (MWSTP) in creating a network encompassing large academic centers and local community sites. We propose a new model utilizing online platforms to expand the reach of clinical expertise for the treatment of advanced soft tissue sarcoma.

AB - The treatment of sarcoma necessitates a collaborative approach, given its rarity and complex management. At a single institution, multidisciplinary teams of specialists determine and execute treatment plans involving surgical, radiation, and medical management. Treatment guidelines for systemic therapies in advanced or nonresectable soft tissue sarcoma have advanced in recent years as new immunotherapies and targeted therapies become available. Collaboration between institutions is necessary to facilitate accrual to clinical trials. Here, we describe the success of the Midwest Sarcoma Trials Partnership (MWSTP) in creating a network encompassing large academic centers and local community sites. We propose a new model utilizing online platforms to expand the reach of clinical expertise for the treatment of advanced soft tissue sarcoma.

KW - Midwest Sarcoma Trials Partnership

KW - advanced soft tissue sarcoma

KW - collaboration

KW - multidisciplinary tumor board

KW - sarcoma treatment

KW - targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=85152939583&partnerID=8YFLogxK

U2 - 10.3390/jcm12072561

DO - 10.3390/jcm12072561

M3 - Article

C2 - 37048645

AN - SCOPUS:85152939583

SN - 2077-0383

VL - 12

JO - Journal of Clinical Medicine

JF - Journal of Clinical Medicine

IS - 7

M1 - 2561

ER -

The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this